أخبار
تجربة سريرية رائدة في العلاج الجيني هي الأولى م...
This is the world's first IRB-approved clinical trial aimed at reversing aging by at least 20 years; it is also the world's most expensive pay-to-play trial with a one million...
تجربة سريرية رائدة في العلاج الجيني هي الأولى م...
This is the world's first IRB-approved clinical trial aimed at reversing aging by at least 20 years; it is also the world's most expensive pay-to-play trial with a one million...